PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportstobacco use cessation
MeSH D020340 - tobacco use cessation
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015438:Health behavior
0 Companies
0 Drugs
Success rate
D020340: 
Tobacco use cessation
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
PfizerVarenicline Champix  2006-09-25   
Clinical Trials
Historical Success Rate
Phase 1
100%
3/3
Phase 2
67%
4/6
Phase 3
80%
4/5
Approved: 1Overall Success rate: 53%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Pfizer
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use